Jacobson Pharma Corporation Limited (2633.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.46B |
| Enterprise Value | 3B |
| P/E Ratio | 7.09 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 1.36 |
| Price/Book Ratio | 0.92 |
| Enterprise/Revenue | 1.71 |
| Enterprise/EBITDA | 5.3 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.23 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 1.57B |
| Revenue/Share | 0.78 |
| Gross Profit | 677.9M |
| EBITDA | 506.97M |
| Net Income | 301.62M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 369.86M |
| Total Cash/Share | 0.18 |
| Total Debt | 910.9M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.37 |
| Book Value Per Share | 1.17 |
Price History
| 52-Week Change | -35.93 |
| 52-Week High | 1.68 |
| 52-Week Low | 0.98 |
| Moving Average 50 Days | 1.09 |
| Moving Average 200 Days | 1.23 |
Statistics
| Average Volume | 321,523 |
| Shares Outstanding | 2B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 14.72 |
| Payout Ratio | 1.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
